Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04722367 · ClinicalTrials.gov registry record · NA
Being Present With Art: The Impact of Mindful Engagement With Art on Awareness and Connection
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT04722367: Completed NA study, sponsored by Yale University.
NCT04722367 is a NA study that has completed, run by Yale University. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04722367, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to observe and measure the impact of mindfulness and art pedagogy on stress levels amongst students.
Primary Outcome
A primary objective of this study is to determine whether mindful engagement with art reduces student stress levels. This will be measured by the Perceived Stress Scale (min = 0; max = 4) which consists of 10 scale items. The higher the score, the more likely participants are stressed. Participants who received the intervention in Session One will be compared to the control (Session Two).
Interventions
- BEHAVIORAL Art Pedagogy and Mindfulness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-09-28 |
| Est. Completion | 2020-11-30 |
| Phase | NA |
What the finished NCT04722367 record still lists
NCT04722367 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Art Pedagogy and Mindfulness is the first listed.
NCT04722367 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04722367 about?
NCT04722367 is a clinical study titled "Being Present With Art: The Impact of Mindful Engagement With Art on Awareness and Connection". The purpose of this study is to observe and measure the impact of mindfulness and art pedagogy on stress levels amongst students.
What is the current status of trial NCT04722367?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2020-09-28. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT04722367?
The interventions under investigation include: Art Pedagogy and Mindfulness (BEHAVIORAL).
Who is sponsoring clinical trial NCT04722367?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04722367's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI